182 related articles for article (PubMed ID: 16378095)
1. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M
Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M
Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
[TBL] [Abstract][Full Text] [Related]
3. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
[TBL] [Abstract][Full Text] [Related]
4. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
Oh IH; Fabry ME; Humphries RK; Pawliuk R; Leboulch P; Hoffman R; Nagel RL; Eaves C
Exp Hematol; 2004 May; 32(5):461-9. PubMed ID: 15145214
[TBL] [Abstract][Full Text] [Related]
5. Targeted beta-globin gene conversion in human hematopoietic CD34(+ )and Lin(-)CD38(-)cells.
Liu H; Agarwal S; Kmiec E; Davis BR
Gene Ther; 2002 Jan; 9(2):118-26. PubMed ID: 11857070
[TBL] [Abstract][Full Text] [Related]
6. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing.
Rivella S; Sadelain M
Semin Hematol; 1998 Apr; 35(2):112-25. PubMed ID: 9565154
[TBL] [Abstract][Full Text] [Related]
7. Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
[TBL] [Abstract][Full Text] [Related]
8. Correction of sickle cell disease in transgenic mouse models by gene therapy.
Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
[TBL] [Abstract][Full Text] [Related]
9. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
[TBL] [Abstract][Full Text] [Related]
10. Current status of globin gene therapy for the treatment of beta-thalassaemia.
Lisowski L; Sadelain M
Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for the hemoglobin disorders.
Persons DA; Nienhuis AW
Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
[TBL] [Abstract][Full Text] [Related]
12. Beta globin gene inhibition by antisense RNA transcripts.
Xu L; Ferry AE; Monteiro C; Pace BS
Gene Ther; 2000 Mar; 7(5):438-44. PubMed ID: 10694826
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy. Gene gemisch cures sickle cell in mice.
Marshall E
Science; 2001 Dec; 294(5550):2268. PubMed ID: 11743172
[No Abstract] [Full Text] [Related]
14. Gene therapy for hemoglobinopathies: are we there yet?
Puthenveetil G; Malik P
Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
[TBL] [Abstract][Full Text] [Related]
15. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of alpha-globin gene expression by RNAi.
Sarakul O; Vattanaviboon P; Wilairat P; Fucharoen S; Abe Y; Muta K
Biochem Biophys Res Commun; 2008 May; 369(3):935-8. PubMed ID: 18328259
[TBL] [Abstract][Full Text] [Related]
17. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
[TBL] [Abstract][Full Text] [Related]
18. Application of SFHR to gene therapy of monogenic disorders.
Goncz KK; Prokopishyn NL; Chow BL; Davis BR; Gruenert DC
Gene Ther; 2002 Jun; 9(11):691-4. PubMed ID: 12032689
[TBL] [Abstract][Full Text] [Related]
19. Modulation of gene expression by siRNA in hematopoietic cells.
Scherr M; Eder M
Curr Opin Drug Discov Devel; 2005 Mar; 8(2):262-9. PubMed ID: 15782549
[TBL] [Abstract][Full Text] [Related]
20. The gamma-globin gene promoter progressively demethylates as the hematopoietic stem progenitor cells differentiate along the erythroid lineage in baboon fetal liver and adult bone marrow.
Singh M; Lavelle D; Vaitkus K; Mahmud N; Hankewych M; DeSimone J
Exp Hematol; 2007 Jan; 35(1):48-55. PubMed ID: 17198873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]